![Rashed Dewan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rashed Dewan
Finanzdirektor/CFO bei PROFOUND MEDICAL CORP.
Vermögen: 175 015 $ am 31.05.2024
Aktive Positionen von Rashed Dewan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PROFOUND MEDICAL CORP. | Finanzdirektor/CFO | 03.03.2022 | - |
Comptroller/Controller/Auditor | 19.05.2021 | 03.03.2022 | |
Personalreferent | - | 03.03.2022 | |
Corporate Officer/Principal | 03.05.2018 | 19.05.2021 |
Karriereverlauf von Rashed Dewan
Ehemalige bekannte Positionen von Rashed Dewan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Profound Medical, Inc.
![]() Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Comptroller/Controller/Auditor | 06.07.2015 | - |
Ausbildung von Rashed Dewan
University of Southern California | Undergraduate Degree |
Statistik
International
Kanada | 3 |
Vereinigte Staaten | 2 |
Operativ
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Human Resources Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PROFOUND MEDICAL CORP. | Health Technology |
Private Unternehmen | 1 |
---|---|
Profound Medical, Inc.
![]() Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- Rashed Dewan
- Erfahrung